Contact information

Thrombotargets Europe, SL
Ramón Béjar
TTE-BARCELONA: Parc Mediterrani de la Tecnologia, Av Canal olímpic s/n, Edif B6, 2ªPlanta,
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • In vitro diagnostics
      • Screening
    • Therapeutic areas
      • Cardiovascular diseases and circulatory system
      • Oncology
      • Blood and lymphatic system
      • Central nervous system

Thrombotargets Europe is a clinical stage Biotech company focused on the development of new therapeutic treatments in the field of haemostasis. To achieve this goal Thrombotargets has developed proprietary High Throughput Screening Technologies that allow the speed-up of the Drug Discovery process for the identification of innovative drugs that may improve the quality of life of the human being.

Products and services
  • TT-173 (Topical Hemostat for treatment of surgical bleeding, Phase II)
  • Several programs focused on haemostasis and coagulation (anticoagulants, antifibrinolytics)
  • Technological Platforms: BIOPLATFORMSCREEN (High Throughput Screening in haemostasis for the detection of anticoagulants, procoagulants, fibrinolytics, antifibrinolytics)
Areas of interest for future collaborations
  • Collaborations in HTS projects; identification and development of new drugs in haemostasis
  • Development of tt-173 containing sealants/patche
  • Biomarkers to be integrated in biosensor-based diagnosis platform (POC in Alzheimer)